{
    "2020-04-27": [
        [
            {
                "time": "2018-03-15",
                "original_text": "Federal Judge Excludes Certain Plaintiff Expert Testimony from Talc Ovarian Cancer Trials, Deeming Them Not Scientifically Sound",
                "features": {
                    "keywords": [
                        "Judge",
                        "Talc",
                        "Ovarian Cancer",
                        "Scientifically Sound"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-04-17",
                "original_text": "U.S. judge rules talc lawsuits against J&J can proceed, testimony limited",
                "features": {
                    "keywords": [
                        "U.S. judge",
                        "talc lawsuits",
                        "J&J",
                        "testimony limited"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-04-17",
                "original_text": "CORRECTED-U.S. judge rules talc lawsuits against J&J can proceed, testimony limited",
                "features": {
                    "keywords": [
                        "U.S. judge",
                        "talc lawsuits",
                        "J&J",
                        "testimony limited"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2020-09-10",
                "original_text": "Emergent BioSolutions, J&J join forces for COVID-19 vaccine manufacturing",
                "features": {
                    "keywords": [
                        "Emergent BioSolutions",
                        "J&J",
                        "COVID-19",
                        "vaccine manufacturing"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2021-04-15",
                "original_text": "Big Drug Stock Q1 Earnings Due on Apr 28: MRK, PFE and NVS",
                "features": {
                    "keywords": [
                        "Q1 Earnings",
                        "MRK",
                        "PFE",
                        "NVS"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-05-10",
                "original_text": "JNJ Submits Japan Filing for New Daratumumab Formulation",
                "features": {
                    "keywords": [
                        "JNJ",
                        "Japan Filing",
                        "Daratumumab",
                        "Formulation"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}